Major adverse cardiovascular events’ reduction and their association with glucose‐lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records

Bibliographic Details
Main Authors:	Haowen Hsu, Paul Thomas Kocis, Ariana Pichardo‐Lowden, Wenke Hwang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction
by: Chih‐Yao Hsu, et al.
Published: (2024)

Advances in continuous glucose monitoring and their impact on glycemic control in diabetes
by: Yi‐Hsuan Lai, et al.
Published: (2026)

Second‐trimester triglyceride‐glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study
by: Xueqi Bai, et al.
Published: (2024)

Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
by: Stephanie A. Hooker, et al.
Published: (2026)

Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
by: Crystal M. Y. Lee, et al.
Published: (2025)

Associations of fasting plasma glucose with all‐cause mortality and cardiovascular events in older Chinese diabetes patients: A population‐based cohort study
by: Linan Wang, et al.
Published: (2024)

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes
by: Tatsuhiko Urakami, et al.
Published: (2024)

Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes‐Heart Project
by: Marta Mantovani, et al.
Published: (2025)

Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study
by: Kristina S. Boye, et al.
Published: (2025)

Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
by: Da Young Lee, et al.
Published: (2025)

The impact of sodium‐glucose co‐transporter‐2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation
by: Yun‐Yu Chen, et al.
Published: (2024)

Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study
by: Dong‐Hoe Koo, et al.
Published: (2025)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
by: Iskandar Idris
Published: (2024)

Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration
by: Yuya Suzuki, et al.
Published: (2026)

Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials
by: Magdaline Zawadka, et al.
Published: (2026)

Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta‐analysis of cardiovascular outcome trials of novel glucose‐lowering agents
by: Setor K. Kunutsor, et al.
Published: (2024)

Cross‐sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes
by: Mika Shimizu, et al.
Published: (2024)

Adherence to physician visits for diabetes care and cardiovascular disease risk: A retrospective cohort study using an administrative claims database
by: Akira Okada, et al.
Published: (2025)

Long‐term glycemic exposure, glycemic control stability and incident calcific aortic valve disease: A prospective cohort study
by: Maoxiang Zhao, et al.
Published: (2025)

Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management
by: Shijun Liu, et al.
Published: (2025)

Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes
by: Amara Sarwal, et al.
Published: (2025)

Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects
by: Xue Fan, et al.
Published: (2024)

Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study
by: Ya‐Hui Yu, et al.
Published: (2024)

Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams
by: Mikkel Thor Olsen, et al.
Published: (2025)

Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long‐term risk of cardiovascular events and mortality
by: Fei Chen, et al.
Published: (2024)

Interactive correlations between artificial light at night, health risk behaviors, and cardiovascular health among patients with diabetes: A cross‐sectional study
by: Yi Zhang, et al.
Published: (2024)

Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes
by: Danielle L. Jones, et al.
Published: (2024)

Higher dietary magnesium intake and lower risks of all‐cause, cardiovascular and kidney disease mortality in diabetes participants: A large cross‐population cohort study
by: Kaiyi Chi, et al.
Published: (2026)

Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus
by: Chinatsu Sakai, et al.
Published: (2025)

Impact of maternal overweight/obesity and high fasting plasma glucose on adverse perinatal outcomes in early gestational diabetes mellitus
by: Noriyuki Iwama, et al.
Published: (2025)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
by: Moscho Michalopoulou, et al.
Published: (2024)

Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures
by: Zachary A. Weber
Published: (2019)

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany
by: Theresia Sarabhai, et al.
Published: (2025)

Effectiveness and safety of once‐weekly subcutaneous semaglutide versus other glucose‐lowering agents in real‐world patients with type 2 diabetes: A retrospective, observational post‐marketing study
by: Chenyang Shi, et al.
Published: (2024)

Glucagon‐like‐peptide‐1 receptor agonists versus dipeptidyl peptidase‐4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study
by: Bochra Zareini, et al.
Published: (2024)

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM
by: Ran Guo, et al.
Published: (2025)

Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial
by: Abderrahim Oulhaj, et al.
Published: (2024)

Vulvovaginal candidiasis and type 2 diabetes: A nationwide retrospective cohort study
by: Emelie Brieditis, et al.
Published: (2024)

Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan
by: Tzu‐Yi Lin, et al.
Published: (2024)

A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
by: Jiewen Guan, et al.
Published: (2025)

Similar Items

Similar Items